LATEST ALERTS
Three key players in the tobacco alternatives market have reported strong results in their most recent quarters, largely driven by performance in next-generation products as consumer demand is on the rise
Altria’s third-quarter results showcased significant growth in its oral tobacco products and a strategic focus on expanding reduced-risk offerings
Japan Tobacco Group (JT) delivered a standout third quarter, fuelled by surging demand in its tobacco and heated products sectors and a significant global expansion
November will mark ten years since Iqos was launched in Japan. And as the third-quarter results of Philip Morris International show, the last ten years have been quite the story in the product’s global brand-building
Philip Morris International (PMI) highlighted the performance of its smoke-free products during its third-quarter results presentation, with the category growing to reach 38% of the company’s total net revenue
Imperial Brands reported trading in line with expectations, driven by robust growth in its tobacco segment and next generation products, as it prepares to give its full-year results in November
Japan Tobacco International reports it delivered a robust performance in the first half of the year, continuing its investment to expand its presence in the heated tobacco segment, with Ploom now available in 21 markets
Oral tobacco continued to significantly contribute to Altria’s numbers in the first half of the year, with encouraging results from its On! nicotine pouch brand and positive On! Plus growth prospects
British American Tobacco reported a drop in first-half revenue, offset by the continued growth of new categories. BAT expects new-category revenue to be weighted in the second half of 2024, driven by phased launches
Philip Morris International recorded an outstanding second-quarter and first-half performance, with strong contributions from Iqos and Zyn – despite supply constraints and the EU flavour ban
Tobacco giant Altria has submitted premarket tobacco product applications (PMTAs) to the US Food and Drug Administration (FDA) for its On! Plus oral nicotine pouch products
Philip Morris International halted online sales of its Zyn nicotine pouches in the US after receiving a subpoena from the District of Columbia attorney general requesting information about sales of flavoured Zyn pouches in DC
Imperial Brands delivered a solid performance for the first half of the year ended 31st March 2024, boosted by scaling up its existing footprint and stepping up innovation across all next-generation product categories
Japan Tobacco International (JTI) delivered a robust performance in the first quarter of 2024, partly thanks to a double-digit increase in reduced-risk product revenue – driven mainly by the heated tobacco sticks segment
Oral tobacco continues to make a significant contribution to Altria’s numbers, as the company reported its results for the first quarter of 2024 with encouraging earnings from its On! nicotine pouch brand
PMI continued reporting its smoke-free momentum in the first quarter of 2024, announcing 25% organic growth in net revenues and 38% in gross profit – with strong contributions from Iqos and Zyn
US-based 22nd Century highlights expansion of its VLN cigarettes distribution and retail network and the sale of its hemp/cannabis business in its 2023 full-year results
Nicotine pouches seemed to be the universal positive for Big Tobacco in 2023, with oral tobacco categories making increasingly important contributions to all the companies involved in that area
South Korean tobacco company KT&G reported a positive performance in its next-generation product (NGP) business over the course of 2023, despite what it called “intensified competition”
Philip Morris International (PMI) delivered a positive performance last year, with smoke-free products reaching almost 40% of the company’s total net revenues as well as gross profit
British American Tobacco (BAT) saw its new category products achieve profitability two years ahead of schedule supported by rapid growth in its Velo nicotine pouch
Oral tobacco continues to make an increasingly important contribution to Altria’s numbers – a trend the firm expects to continue, it said as it reported its fourth-quarter and full-year results for 2023
Haypp Group, an online retailer of reduced-risk products, will look to expand into new categories and European markets following the success of a vaping pilot in the UK
US-based 22nd Century will sell its hemp/cannabis subsidiary, GVB Biopharma, to an entity affiliated with current GVB employees and will use the sale proceeds to pay off debt and further deleverage its balance sheet
KT&G reported record-high quarterly revenues for the third quarter of 2023, with a significant contribution from its next generation product (NGP) category, as part of its release on the quarter’s financial results
Imperial Brands reported a performance in line with its five-year-plan expectations in the year ended 30th September 2023, with new product and market launches boosting its next-generation product (NGP) revenue
22nd Century is already demonstrating its commitment to expand its intellectual property in the area of reduced-nicotine tobacco, which it said it would undertake during a presentation of its third quarter results
US company 22nd Century has reported decreased revenues and modest sales of its VLN brand very-low-nicotine cigarette products in the third quarter of 2023, despite the continued expansion of its VLN rollout strategy
Japan Tobacco International (JTI) enjoyed a solid performance in the third quarter of the year, partially related to its Ploom X heated tobacco product geographic expansion
Altria saw a “resilient” performance over the course of the first nine months of 2023, the company said as it reported its results for the third quarter of the year
Philip Morris International (PMI) has submitted premarket tobacco product applications (PMTAs) and modified risk tobacco product applications (MRTPAs) to the US FDA for its Iqos Iluma heated tobacco products (HTPs)
Strong sales momentum behind PMI’s Zyn nicotine pouches in the US helped drive the company’s growth in the third quarter, with US sales volume up nearly 66% on the same quarter in 2022
KT&G anticipates that alternative nicotine products will continue to make up greater proportions of its sales, the company said during a presentation of its second-quarter results
22nd Century will focus on streamlining operating costs and making the marketing and sales push for its VLN cigarette products more cost efficient to address issues that have forced it to revise full-year profit guidance
Japan Tobacco (JT) is to ramp up investment in its production of heated tobacco sticks over the second half of 2023 after reporting better than expected results for the first six months of the year
Altria reported a solid performance in the first half of 2023 despite lower net revenues, partially offset by higher revenue in the oral tobacco segment
British American Tobacco (BAT) has reported a continued positive performance of its vapour and modern oral segment but said it needs to do more work on its heated tobacco products
US company 22nd Century will look to expand its international interests by launching trials in Switzerland and Japan as well as relaunching its low-nicotine conventional cigarette product in South Korea
Japan Tobacco International (JTI) enjoyed a solid performance in the first three months of the year, boosted by a successful launch of its Ploom X heat-not-burn (HnB) device in Italy and Lithuania
US tobacco giant Altria closed the first quarter of 2023 with a slight fall in its net revenues compared with the same period last year, while it recorded an increase in its adjusted diluted earnings per share (EPS)
Philip Morris International will focus on heated tobacco and nicotine pouches as the alternatives that can help it meet its goal of becoming a majority smoke-free revenue company by 2025
Expanding sales of next generation products into new markets has more than compensated Imperial Brands for the enforced loss of its Myblu e-cigarette from the US market
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
